Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 8 min ago
Peer-reviewedCC BY-NC-ND 4.0Journal of Intensive Medicine

Sex-related differences in antimicrobial dosing for sepsis: Bridging the equity gap

Abstract

Sepsis, defined as life-threatening organ dysfunction caused by a dysregulated host response to infection, remains a major challenge in critical care and a leading cause of mortality worldwide. Early, appropriate antibiotic administration is among the most effective strategies to improve outcomes, making optimization of antimicrobial therapy a priority. Optimal antibiotic therapy is the careful selection of the agent and dosing regimen that optimizes outcomes while minimizing adverse effects and antimicrobial resistance. Yet, paradoxically, dosing regimens in sepsis often rely on standardized protocols that overlook fundamental biological variables such as sex and gender, as well as intersecting factors like socioeconomic status, ethnicity, and access to care. This omission compromises efficacy and perpetuates clinical inequalities [...].

Related

  1. From Host Response to Microbiological Risk: Association of the RIN-IM Score with Culture-Positive Sepsis and Antimicrobial Resistance in Critically Ill Adults
    Davut Ipek, Yusuf Ipek, Recep Dokuyucu
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. A novel meropenem dosing strategy for Outpatient Parenteral Antimicrobial Therapy (OPAT): a pilot pharmacokinetic/pharmacodynamic study in non-critically ill patients
    Caroline Briquet, Perrin Ngougni Pokem, Xin Liu +7
    Antimicrobial Agents and ChemotherapyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyHAL
  3. Procalcitonin and Presepsin in Gram-Negative Sepsis: Diagnostic, Prognostic, and Antimicrobial Stewardship Perspectives
    Bhaskar C Yadav, Harsha V Patil, Satish R Patil
    CureusPeer-reviewedCC BYFull textInfectious diseaseObstetrics, gynaecology & paediatricsEurope PMCPMC
  4. Chimeric IL‐6/4R‐LL37 Engineered Macrophages Achieve Synchronized Inflammation Control and Antimicrobial Defence in Sepsis
    Tianyang Jie, Zheyu Zhang, Hao Zhang +8
    Advanced SciencePeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
  5. Before Sepsis Strikes: Artificial Intelligence for Early Prediction of Postoperative Sepsis and Sepsis-Related Complications After Major Abdominal Surgery—A Systematic Review
    Wasim Iyad Ibrahim Alghoul, Ibrahim Alabid, Malak Moones Abedi +9
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{barrasa2026sexrelated,
  title = {{Sex-related differences in antimicrobial dosing for sepsis: Bridging the equity gap}},
  author = {Helena Barrasa and Goiatz Balziskueta and Jordi Rello},
  journal = {Journal of Intensive Medicine},
  year = {2026},
  month = oct,
  doi = {10.1016/j.jointm.2025.08.004},
  url = {https://hal.science/hal-05806389v1},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Sex-related differences in antimicrobial dosing for sepsis: Bridging the equity gap
AU  - Helena Barrasa
AU  - Goiatz Balziskueta
AU  - Jordi Rello
PY  - 2026
DA  - 2026/10/19
JO  - Journal of Intensive Medicine
DO  - 10.1016/j.jointm.2025.08.004
UR  - https://hal.science/hal-05806389v1
AB  - Sepsis, defined as life-threatening organ dysfunction caused by a dysregulated host response to infection, remains a major challenge in critical care and a leading cause of mortality worldwide. Early, appropriate antibiotic administration is among the most effective strategies to improve outcomes, making optimization of antimicrobial therapy a priority. Optimal antibiotic therapy is the careful selection of the agent and dosing regimen that optimizes outcomes while minimizing adverse effects and antimicrobial resistance. Yet, paradoxically, dosing regimens in sepsis often rely on standardized protocols that overlook fundamental biological variables such as sex and gender, as well as intersecting factors like socioeconomic status, ethnicity, and access to care. This omission compromises efficacy and perpetuates clinical inequalities [...].
SN  - 2667-100X
ER  -